PT - JOURNAL ARTICLE AU - Kodesh, Arad AU - Levine, Stephen Z. AU - Khachadourian, Vahe AU - Rahman, Rayees AU - Schlessinger, Avner AU - O’Reilly, Paul F. AU - Grove, Jakob AU - Schendel, Diana AU - Buxbaum, Joseph D. AU - Croen, Lisa AU - Reichenberg, Abraham AU - Sandin, Sven AU - Janecka, Magdalena TI - Maternal health around pregnancy and autism risk: a population-based study AID - 10.1101/2020.05.19.20089581 DP - 2020 Jan 01 TA - medRxiv PG - 2020.05.19.20089581 4099 - http://medrxiv.org/content/early/2020/05/22/2020.05.19.20089581.short 4100 - http://medrxiv.org/content/early/2020/05/22/2020.05.19.20089581.full AB - IMPORTANCE Many maternal diagnoses in pregnancy have been linked with offspring ASD risk. However, pregnant women receive many other diagnoses, most of which have not been evaluated for an association with offspring ASD.OBJECTIVE Systematically test the associations between maternal diagnoses around pregnancy, and ASD risk in offspring, filtering out potential false positives and accounting for correlation between maternal diagnoses.DESIGN, SETTING AND PARTICIPANTS This case-cohort study included children born in Israel from January 1, 1999, through December 31, 2008, and followed up until January 26, 2015. We used information on all ICD-9 codes received by their mothers during pregnancy and the preceding year. ASD risk in children whose mothers experienced each of those conditions during the exposure period was compared with ASD risk in unexposed children. Data were analyzed from December 1, 2019, through April 30, 2020.MAIN OUTCOME AND MEASURES Hazard ratios (HRs) and 95% confidence intervals (CIs) of ASD risk associated with each maternal ICD-9 code, calculated using Cox proportional hazards regression, adjusted for the confounders (birth year, maternal age, socioeconomic status and number of ICD-9 diagnoses during the exposure period).RESULTS The analytic sample consisted of 80,187 individuals (1,132 cases, 79,055 controls; median [interquartile range] age at the end of follow up was 11.2 [8.8-13.6]; 48.8% female). Of 822 ICD-9 codes tested, 148 were recorded in at least 10 of each case and control mothers. Of those, 22 maternal diagnoses were nominally significantly associated with offspring ASD, and 16 of those survived subsequent filtering steps (permutation testing, multiple testing correction, multiple regression). Among those 16 diagnoses, we recorded increased risk of ASD associated with certain metabolic (e.g. hypertension (ICD-9 401); HR=2.74(1.92-3.90), P=2.43E-8), genitourinary (e.g. noninflammatory disorders of cervix (ICD-9 622); HR=1.88(1.38-2.57), P=7.06E-5) and psychiatric (depressive disorder (ICD-9 311); HR=2.11(1.32-3.35), P=1.70E-3) diagnoses. Meanwhile, mothers of children with ASD were less likely to attend prenatal care appointment (ICD-9 V22; HR=0.62 (0.54-0.71), P=1.80E-11).CONCLUSIONS AND RELEVANCE We observed an association between ASD and 16 maternal ICD-9 diagnoses, after rigorous filtering out potential false positive associations. Replication in other cohorts and further research to understand the mechanisms underlying the observed associations with ASD are warranted.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunding/Support: This study was supported in part by grant HD073978 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institute of Environmental Health Sciences, and National Institute of Neurological Disorders and Stroke (Drs Reichenberg, Kodesh, Levine); and by grant HD098883 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (Drs Reichenberg, Sandin, Schendel, Buxbaum). Role of the Funder/Sponsor: The sponsors had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData access rules do not permit public sharing of the data. Interested researchers should discuss access options with Arad Kodesh and Stephen Levine.